Thyroid Medication for Elderly Parents — What Caregivers Should Know

Your father's doctor called after routine bloodwork and mentioned his TSH was suppressed. Then there was a referral to an endocrinologist, mention of something called Graves disease, and a prescription you've never heard of. You left the appointment with more questions than answers, and your father — who has never been good at remembering what doctors tell him — can't recall the specifics.

Thyroid problems are common in older adults, and both overactive (hyperthyroidism) and underactive (hypothyroidism) thyroid conditions are frequently managed with medications that require careful monitoring. For caregivers, understanding what these medications do, why they're prescribed, and what to watch for at home is an important part of managing a parent's overall health picture.

This guide focuses on hyperthyroidism and Graves disease — conditions where the thyroid produces too much hormone — and the medications used to treat them.

What is Graves disease, and why does it matter in elderly patients?

Graves disease is an autoimmune condition in which the immune system mistakenly stimulates the thyroid gland to produce excessive amounts of thyroid hormone (hyperthyroidism). It is the most common cause of hyperthyroidism in adults, though in older adults, another condition called toxic nodular goiter (where overactive nodules develop independently in the thyroid) becomes increasingly common.

Hyperthyroidism in elderly adults often looks different than it does in younger patients — and that difference is what makes it dangerous if missed.

Typical hyperthyroidism symptoms in younger adults:

• Rapid heart rate
• Weight loss despite increased appetite
• Anxiety and tremors
• Heat intolerance and sweating
• Bulging eyes (in Graves disease specifically)

How it often presents in elderly adults instead:

• Unexplained weight loss
• New atrial fibrillation or worsening heart rhythm problems
• Fatigue and muscle weakness rather than the restlessness typical in younger patients
• Depression or apathy rather than anxiety
• Heart failure exacerbation

This more muted presentation — sometimes called "apathetic hyperthyroidism" — means elderly patients are often diagnosed later, and by the time the thyroid problem is identified, a parent may already have complications from months of uncontrolled hyperthyroid state.

The three treatment options for hyperthyroidism

There are three main approaches to treating hyperthyroidism. In elderly patients, the choice between them depends on the cause, severity, overall health, and what other conditions and medications are already in play.

1. Antithyroid medications

The two antithyroid drugs used in the United States and internationally are:

• Methimazole (Tapazole) — the preferred first-line antithyroid medication for most patients, including elderly adults
• Propylthiouracil (PTU) — generally reserved for specific situations (first trimester of pregnancy, thyroid storm, or when methimazole is not tolerated)

Both drugs work by blocking the thyroid's ability to produce new thyroid hormone. They do not destroy the thyroid or cure the underlying condition — they manage hormone levels while waiting for the condition to potentially go into remission (in Graves disease) or as a bridge before more definitive treatment.

Timeline: Antithyroid drugs typically take 4 to 8 weeks to bring thyroid hormone levels under control. During this period, a beta-blocker (most commonly propranolol or atenolol) is often prescribed alongside to control the heart rate and physical symptoms while waiting for the antithyroid drug to work.

Monitoring requirements: Thyroid function tests (TSH, Free T4, Free T3) need to be checked regularly — typically every 4 to 8 weeks when dose adjustments are being made, then every 3 to 6 months once stable. The dose needs adjustment as levels normalize; too much antithyroid medication will cause hypothyroidism (underactive thyroid), which creates its own set of problems.

Side effects to monitor in elderly patients:

• Agranulocytosis — a rare but serious reduction in white blood cells that can make the patient highly vulnerable to infection. It typically occurs within the first 90 days of treatment. Warning signs include fever, sore throat, or mouth sores. If your parent develops a sudden high fever while on methimazole or PTU, this is a medical emergency — call the doctor immediately and stop the medication until a white blood cell count can be checked.
• Liver problems — PTU in particular carries a risk of liver toxicity, which is one reason methimazole is preferred for most patients.
• Rash and joint pain — mild skin rash occurs in 5 to 10 percent of patients; usually managed by switching to the other antithyroid drug.

Interaction watch: Both methimazole and PTU interact with warfarin (blood thinner). Hyperthyroidism itself increases warfarin sensitivity, and as thyroid levels are brought under control, warfarin requirements change. If your parent takes warfarin and has been diagnosed with hyperthyroidism, the anticoagulation monitoring schedule will need to increase during treatment adjustments.

2. Radioactive iodine (RAI) therapy

Radioactive iodine is a one-time oral treatment (usually a capsule or liquid) that is absorbed by the thyroid gland. The radioactive iodine gradually destroys thyroid tissue, reducing hormone production. It is the most commonly used definitive treatment for hyperthyroidism in the United States.

Outcome: Most patients will eventually become hypothyroid after RAI, meaning the thyroid will not produce enough hormone on its own. This is expected and managed with lifelong levothyroxine (synthetic thyroid hormone replacement). It is not a failure of treatment — it's a predictable outcome that most endocrinologists plan for.

Why it may be preferred for elderly adults: It avoids the need for ongoing medication, eliminates the risk of drug side effects over years, and is highly effective. For an elderly patient with a stable heart and no contraindications, RAI is often the preferred definitive treatment.

Why it may be delayed or avoided: Patients with active Graves eye disease (thyroid eye disease with significant eye changes) may not be candidates for RAI, as it can temporarily worsen eye symptoms. Patients with severe or uncontrolled hyperthyroidism may need to be stabilized on antithyroid drugs first before RAI.

Post-treatment monitoring: After RAI, thyroid levels need to be checked at 6 weeks, then again at 3 months, and periodically thereafter. Hypothyroidism can develop months to years after treatment, so ongoing monitoring matters even when levels initially look normal.

3. Thyroid surgery (thyroidectomy)

Surgery to remove part or all of the thyroid is the least common treatment for hyperthyroidism and is generally not a first-line choice in elderly patients due to surgical risk. It may be considered if the thyroid is very large, causing compression symptoms, or if other treatments are not suitable.

Post-surgery, patients who had a total thyroidectomy require lifelong levothyroxine replacement.

Levothyroxine — the thyroid hormone replacement connection

Whether your parent has hypothyroidism (underactive thyroid, the more common condition in elderly adults) or develops it after hyperthyroidism treatment, levothyroxine (Synthroid, Euthyrox) is the standard replacement medication.

Levothyroxine requires careful attention to timing and interactions — more than most caregivers realize.

Take on an empty stomach: Levothyroxine should be taken first thing in the morning, 30 to 60 minutes before food. Food — particularly high-fiber foods and coffee — significantly reduces absorption.

The 4-hour rule for supplements: Calcium, iron supplements, antacids, and many multivitamins bind to levothyroxine in the gut and prevent it from being absorbed. These should be taken at least 4 hours after levothyroxine — ideally at lunch or dinnertime if the parent takes the thyroid medication at breakfast.

Interactions with other common medications:

• Calcium-containing antacids (Tums, Rolaids) — very common in elderly patients; must be separated by 4 hours
• Proton pump inhibitors (omeprazole, pantoprazole) — can reduce levothyroxine absorption; tell the doctor if your parent takes a PPI regularly
• Cholestyramine and colestipol (bile acid sequestrants for cholesterol) — significantly reduce absorption; must be taken 4 to 6 hours apart
• Warfarin — levothyroxine can increase warfarin sensitivity; when thyroid levels are adjusted, warfarin INR monitoring needs to increase

What undertreated hypothyroidism looks like: If levothyroxine isn't being absorbed or the dose isn't right, symptoms include fatigue, weight gain, constipation, cold intolerance, and cognitive slowing. In elderly patients, this can be mistaken for depression, dementia, or normal aging. If your parent is on levothyroxine and seems to be getting more confused or fatigued, ask the doctor to check TSH.

Beta-blockers as symptom management

Beta-blockers are frequently prescribed alongside antithyroid medications during the initial phase of hyperthyroidism treatment to control the rapid heart rate, palpitations, and tremor that thyroid hormone excess causes. Common choices include:

• Propranolol — the most studied beta-blocker for this purpose
• Atenolol — often preferred in elderly patients with breathing concerns (COPD, asthma), as it is more selective than propranolol

What caregivers should know: Beta-blockers in elderly adults increase fall risk by lowering blood pressure and blunting the heart rate response to exertion. This is a particular concern in the early weeks of treatment. Watch for dizziness when your parent stands up, difficulty on stairs, or falls. Report these symptoms to the doctor — the dose may need adjustment.

Beta-blockers should not be stopped abruptly, particularly in patients with heart disease. If your parent runs out of the prescription, do not wait to refill it.

The monitoring cadence — what to expect

For a caregiver managing a parent on thyroid medication, the monitoring schedule can feel overwhelming at first. Here is a rough guide to what is typically expected:

During active hyperthyroidism treatment (antithyroid drugs):

• Thyroid function tests every 4 to 8 weeks while adjusting dose
• CBC (blood count) if fever or signs of infection develop
• Liver function if PTU is used

After RAI treatment:

• Thyroid function at 6 weeks, 3 months, then every 3 to 6 months until stable

Long-term on levothyroxine:

• TSH once a year if stable and on a consistent dose
• After any dose change: TSH at 6 to 8 weeks

Keeping the complete picture

Thyroid conditions interact with other parts of the body in ways that create downstream medication management challenges. Uncontrolled hyperthyroidism can precipitate atrial fibrillation, requiring anticoagulation. Levothyroxine interacts with cholesterol medication timing, calcium supplementation, and blood thinners. These cross-connections are exactly why a complete, current medication list — one that travels to every appointment — is essential.

If you're managing multiple medications for a parent, including thyroid treatment, the Medication Management Kit includes a master medication record template that captures drug name, dose, timing, prescribing doctor, and purpose for each medication. It also includes a reminder about timing-sensitive medications like levothyroxine — a detail that often gets lost in the shuffle of a busy household.

The goal isn't to become your parent's pharmacist. It's to be informed enough to catch problems before they become crises, and to walk into every appointment with the right questions ready.